ac investment research

Should I Buy NSE:NATCOPHARM Stock? (20% Forecasted Return)



If, for example, a facility matured in 18 months, we could include the borrowing availability as a source of liquidity in year one, but exclude the amount in year two under the exceptional and strong descriptors (as well as include any drawn portions as debt maturities under uses of liquidity). This is because we do not assume an extension of bank lines--regardless of the company's perceived credit strength or issuer credit rating. For instance, whether the issuer credit rating on the company is speculative grade or investment grade, we do not assume bank lines will be extended beyond the current stated maturity.The various qualitative factors in the criteria help to identify strengths and weaknesses within a company's future liquidity position that numerical ratios might not fully capture. While there is no size bias in our liquidity assessment, generally, lower-rated entities might meet the quantitative requirements for strong or exceptional liquidity but fail to meet corresponding qualitative factors.In addition, a speculative-grade company's access to the credit markets during times of stress, such as the financial crisis, is often a function of the capital market's appetite for risk. Accordingly, it would be rare that we would characterize a speculative-grade company as having a generally high standing in the credit markets, and even low-investment-grade companies may not have access to a diversity of funding sources required for this assessment. We estimate NATCOPHARM Natco Pharma Limited stock forecast parameters by: Delay-Line Oscillators with Simple Regression because of core capital, as measured by adjusted common equity, comprises more than 90% of the TAC, or double leverage is less than 90% (20% Forecasted Return)

NSE:NATCOPHARM Price Targets, Stock Forecast (Buy or Sell) as of 14 Jun 2022 for (n+16 weeks)

Stock: NATCOPHARM Natco Pharma Limited

Time series to forecast n: 14 Jun 2022 for (n+16 weeks)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


Frequently Asked QuestionsQ: Is NSE:NATCOPHARM buy or sell?
A: If, for example, a facility matured in 18 months, we could include the borrowing availability as a source of liquidity in year one, but exclude the amount in year two under the exceptional and strong descriptors (as well as include any drawn portions as debt maturities under uses of liquidity). This is because we do not assume an extension of bank lines--regardless of the company's perceived credit strength or issuer credit rating. For instance, whether the issuer credit rating on the company is speculative grade or investment grade, we do not assume bank lines will be extended beyond the current stated maturity.
Q: Is NSE:NATCOPHARM expected to go up?
A: The various qualitative factors in the criteria help to identify strengths and weaknesses within a company's future liquidity position that numerical ratios might not fully capture. While there is no size bias in our liquidity assessment, generally, lower-rated entities might meet the quantitative requirements for strong or exceptional liquidity but fail to meet corresponding qualitative factors.
Q: Do analysts recommend investors buy shares of NATCOPHARM Natco Pharma Limited ?
A: In addition, a speculative-grade company's access to the credit markets during times of stress, such as the financial crisis, is often a function of the capital market's appetite for risk. Accordingly, it would be rare that we would characterize a speculative-grade company as having a generally high standing in the credit markets, and even low-investment-grade companies may not have access to a diversity of funding sources required for this assessment.
Q: What is the the stock symbol of NATCOPHARM Natco Pharma Limited ?
A: NSE:NATCOPHARM
Q: What are the risks of investing NSE:NATCOPHARM ?
A: We use risk analysis for NSE:NATCOPHARM because of core capital, as measured by adjusted common equity, comprises more than 90% of the TAC, or double leverage is less than 90%


AC Investment Research

In our experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.

301 Massachusetts Avenue Cambridge, MA 02139 667-253-1000 pr@ademcetinkaya.com